Change in the Presentation of Research and Development Expenses
First written in FY2025-Q1. 1 of 3 entries say "Restated". Latest entry: FY2025.
0 other companies' latest entry also says "Other".
- FY2025Full-Year R&D Expense DisclosureAnnual report
「Total costs related to research and development activities for the current consolidated fiscal year were ¥839 million.」
The method of presenting research and development costs as research and development expenses continued to be applied, and full-year research and development expenses were ¥839 million. - FY2025-H1RestatedAnnual report
「The Group's total research and development expenses for the current interim consolidated accounting period were ¥418 million. The Group has presented costs incurred for research and development as research and development expenses from the beginning of the current interim consolidated accounting period to more appropriately reflect the substance of its research and development activities in its interim consolidated financial statements.」
The presentation method for research and development expenses continued to be applied, and research and development expenses for the current interim consolidated accounting period were ¥418 million. - FY2025-Q1First statedAnnual report
「To reflect the substance of the Group’s R&D activities more appropriately in the quarterly consolidated financial statements, the Company began presenting costs incurred for R&D as R&D expenses from the beginning of the first quarter of the current fiscal year.」
The Company introduced the policy of presenting costs incurred for R&D as R&D expenses from the beginning of the first quarter to better reflect the substance of its R&D activities.